drugset / Trial / NCT02946034
Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C
NaSingle-groupOpen-labelTreatment
Summary
Open-label experimental trial of 12 weeks of Viekira Pak treatment ± ribavirin or Mavyret for adults with chronic kidney disease and hepatitis C.
Timeline
- Start
- 2017-02-01
- Primary completion
- 2020-09-16
- Completion
- 2020-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribavirin | Small molecule | — | — |
| Subject | dasabuvir | Small molecule | — | — |
| Subject | glecaprevir | Other / unclassified | — | — |